ARHQ Methodology Checklist for Cross-sectional study (http://www.ncbi.nlm.nih.gov/books/NBK35156/) |
Stavroulopoulos et al. | Huang et al. | Ersoy et al. | Orlic et al. | Baszko-Blaszyk et al. | Fidan et al. | Sit et al. | Aggarwal et al. |
---|---|---|---|---|---|---|---|---|
1. Define source of information (survey, record, review) | + | + | + | + | + | + | + | + |
2. List inclusion and exclusion criteria for exposed and unexposed subjects (cases and controls) or refer to previous publications | + | + | + | + | - | + | + | + |
3. Indicate time period used for identifying patients | - | + | - | - | - | + | - | - |
4. Indicate whether or not subjects were consecutive if not population-based | - | + | U | U | - | + | U | - |
5. Indicate if evaluators of subjective components of study were masked to other aspects of the status of the participants | + | + | - | + | + | + | - | + |
6. Describe any assessments undertaken for quality assurance purposes (e.g., test/retest of primary outcome measurements) | + | + | U | + | - | + | + | + |
7. Explain any patient exclusions from analysis | + | - | - | + | - | + | - | + |
8. Describe how confounding was assessed and/or controlled | + | + | + | + | + | + | + | + |
9. If applicable, explain how missing data were handled in the analysis | NA | NA | U | NA | - | + | NA | NA |
10. Summarize patient response rates and completeness of data collection | + | + | - | - | U | + | - | + |
11. Clarify what follow-up, if any, was expected and the percentage of patients for which incomplete data or follow-up was obtained | NA | + | NA | U | - | NA | NA | NA |